Your institution may have access to this item. Find your institution then sign in to continue.
Title
Royalty Pharma bids US$6.6bn for Elan.
Abstract
The article reports that Royalty Pharma, a pharmaceuticals investment company, has rolled out a 6.6 billion U.S. dollars bid for Irish drug manufacturer Elan.